“…The clinical characteristics of BMS in turn suggest the possible participation of neuronal inflammation in the etiopathogenesis of the syndrome, together with a series of other mechanisms (9,10). Many treatments have been recommended for improving the symptoms of BMS, including sialogogues, topical anesthetics in rinses, anxiolytic drugs, antidepressants, anticonvulsivants, alpha-lipoic acid and psychotherapy (8,(9)(10)(11)(12)(13), though no evidence has been produced by controlled clinical trials in support of such therapies. The best results have been reported for clonazepam, administered both topically and via the systemic route, though improvement has not been documented in all cases (14,15).…”